First Trust Advisors LP Embecta Corp. Transaction History

First Trust Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$12.35 - $19.33 $927,262 - $1.45 Million	75,082 Added 129.76%	132,943 $1.76 Million
Q4 2023 Feb 13, 2024	BUY	$12.87 - $19.09 $251,248 - $372,674	19,522 Added 50.92%	57,861 $1.1 Million
Q3 2023 Nov 13, 2023	SELL	$15.0 - $22.17 $408,450 - $603,689	-27,230 Reduced 41.53%	38,339 $577,000
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $822,679 - $1.17 Million	38,087 Added 138.59%	65,569 $1.42 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $184,167 - $261,602	7,983 Added 40.94%	27,482 $772,000
Q4 2022 Feb 09, 2023	BUY	$25.29 - $35.48 $493,129 - $691,824	19,499 New	19,499 $493,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.12B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.